Viewpoint Molecular Targeting, Inc.

United States · 13 Employees
Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company's leading 𝛼-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which provide the opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments. The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-𝛼-NET) programs are entering Phase 1 imaging studies, to be followed by Phase 1/2a therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at two leading academic institutions.

概述

国家 United States
成立时间 2008
总部 2500 Crosspark Rd, E112, Coralville, Iowa 52241, US
电话号码 +1 865-356-1861
网站 http://www.viewpointmt.com
LinkedIn http://www.linkedin.com/company/viewpointmt
Twitter https://twitter.com/Viewpoint_MT
Facebook
员工数 13
行业 pharmaceuticals,
简介 Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company's leading 𝛼-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which provide the opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments. The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-𝛼-NET) programs are entering Phase 1 imaging studies, to be followed by Phase 1/2a therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at two leading academic institutions.

技术

Apache

Load Balancers

Gmail

Email Providers

Google Apps

Other

Google Font API

Fonts

Google Tag Manager

Tag Management

Microsoft Office 365

Other

Mobile Friendly

Other

Outlook

Email Providers

Vimeo

Online Video Platforms

WordPress.org

CMS

常见问题

Viewpoint Molecular Targeting, Inc. 在哪里?

Viewpoint Molecular Targeting, Inc. 的总部位于 2500 Crosspark Rd, E112, Coralville, Iowa 52241, US

Viewpoint Molecular Targeting, Inc. 的电话号码是多少?

Viewpoint Molecular Targeting, Inc. 的电话号码是 +1 865-356-1861

Viewpoint Molecular Targeting, Inc. 的官方网站是什么?

Viewpoint Molecular Targeting, Inc. 的公司官方网站是 http://www.viewpointmt.com

Viewpoint Molecular Targeting, Inc. 是做什么的?

Viewpoint Molecular Targeting, Inc. 的业务有哪些?

Viewpoint Molecular Targeting, Inc. 的年收入是多少?

Viewpoint Molecular Targeting, Inc. 的收入是 2400000美元

Viewpoint Molecular Targeting, Inc. 有多少员工?

Viewpoint Molecular Targeting, Inc. 有 13 名员工

Viewpoint Molecular Targeting, Inc. 属于哪个行业?

Viewpoint Molecular Targeting, Inc. 从事以下行业: pharmaceuticals

Viewpoint Molecular Targeting, Inc. 使用什么技术?

Viewpoint Molecular Targeting, Inc. 使用的一些流行技术包括: Apache,Gmail,Google Apps,Google Font API,Google Tag Manager,Microsoft Office 365,Mobile Friendly,Outlook,Vimeo,WordPress.org

如何联系 Viewpoint Molecular Targeting, Inc.?

Viewpoint Molecular Targeting, Inc. 联系信息: 电话号码:+1 865-356-1861, 网站:http://www.viewpointmt.com, 邮箱:ema***@***.com

Viewpoint Molecular Targeting, Inc. 的社交媒体链接是什么?

Viewpoint Molecular Targeting, Inc. 领英:http://www.linkedin.com/company/viewpointmt,fackbook:,twitte:https://twitter.com/Viewpoint_MT

Viewpoint Molecular Targeting, Inc. 是一家上市公司吗?

不是

Viewpoint Molecular Targeting, Inc. 的最后一轮融资是什么时候?

Viewpoint Molecular Targeting, Inc.在2021-01-21T00:00:00.000+00:00结束了最后一轮融资,金额达5M$。

谁投资 Viewpoint Molecular Targeting, Inc.?

Viewpoint Molecular Targeting, Inc. 有 7 家投资者,包括 National Cancer Institute、、、、National Institutes of Health、、。

管理层

Kelly

Senior Principal Scientist

David Hauser

Vice President Project Management

Michael McDonald

Senior Medical Director

Alexa Jans

Program Manager

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google